首页 正文

Progress in the Treatment of Refractory Myasthenia Gravis

{{output}}
Myasthenia gravis (MG) is an autoantibody-mediated, cellular immune-dependent and complement system-involved autoimmune disorder characterized by acquired neuromuscular junction transmission dysfunction driven by genetic and environmental factors. Approximatel... ...